Streetbeat News

Price Targets

SPOT

Over the past 3 months, 29 analysts have published their opinion on Spotify Technology (NYSE:SPOT) stock. The company has an average price target of $162.28 with a high of $205.00 and a low of $120.00. This average price target has increased by 11.92% over the past month.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 12:00 pm

SHOP

Credit Suisse analyst Timothy Chiodo has maintained a Neutral rating on Shopify (NYSE:SHOP) and raised the price target from $53 to $55.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:59 am

AEL

Truist Securities analyst Mark Hughes has downgraded American Equity Inv (NYSE:AEL) from Buy to Hold, while raising the price target from $49 to $55.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:51 am

APYX

Stephens & Co. analyst George Sellers has initiated coverage on Apyx Medical (NASDAQ:APYX) with an Overweight rating and a price target of $8.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:47 am

LESL

Telsey Advisory Group has maintained a 'Market Perform' rating on Leslies (NASDAQ:LESL) but has lowered the price target from $11 to $8.5.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 11:46 am

DAL

Raymond James analyst Savanthi Syth has maintained a Strong Buy rating on Delta Air Lines (NYSE:DAL) and raised the price target from $57 to $58.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:31 am

MSCI

Raymond James analyst Patrick O'Shaughnessy has maintained an 'Outperform' rating on MSCI (NYSE:MSCI) and raised the price target from $570 to $574.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:30 am

TOL

Raymond James analyst Buck Horne has upgraded Toll Brothers (NYSE:TOL) from Outperform to Strong Buy and raised the price target from $77 to $100.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:27 am

EPR

Raymond James analyst RJ Milligan has downgraded EPR Properties (NYSE:EPR) from Strong Buy to Outperform and set a price target of $50.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:25 am

BDTX

Piper Sandler analyst Joseph Catanzaro has initiated coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with an Overweight rating and a price target of $11.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 11:22 am